Una candidatura completa en un minuto
Currículum y carta de presentación personalizados, listos para enviar.
Georgetown University Medical Center's Golestaneh Laboratory seeks a motivated postdoctoral fellow to join our AMD research program focused on cellular and metabolic mechanisms underlying retinal degeneration. The role involves investigating mitochondrial function, metabolism, autophagy/mitophagy, and lipid homeostasis in RPE cells.
Applicants should have a PhD, MD/PhD, or equivalent in neuroscience, vision science, cell biology, or related field. U.S.
Golestaneh Laboratory, Georgetown University Medical Center, Washington, DC
The Golestaneh Laboratory in the Department of Ophthalmology at Georgetown University Medical Center is seeking a highly motivated postdoctoral fellow to join our research program investigating the cellular and metabolic mechanisms underlying age-related macular degeneration (AMD).
Our laboratory studies how alterations in mitochondrial function, cellular metabolism, autophagy/mitophagy, and lipid homeostasis in the retinal pigment epithelium (RPE) contribute to retinal degeneration and AMD. Current projects integrate human iPSC-derived RPE, cellular and molecular models of RPE dysfunction, in vivo mouse models, advanced imaging, metabolic assays, and human retinal tissues.
Applicants should have a PhD, MD/PhD, or equivalent doctoral degree in a relevant field such as neuroscience, vision science, cell biology, molecular biology, metabolism, biochemistry, stem-cell biology, or a related discipline.
Applicants must be U.S. citizens or permanent residents (green card holders) to be eligible for the available training support.
Experience in one or more of the following areas would be particularly valuable:
Candidates should have strong scientific curiosity, excellent communication skills, and an interest in developing an independent research career. The fellow will be encouraged to publish their work, present at national and international scientific meetings, and develop fellowship and grant applications.
The position is anticipated to begin immediately and before August 31st 2027.